Ji Cao
Impact in
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Geriatrics and Gerontology top 2%
Papers in
-
- Ubiquitin and proteasome pathways 31
- Protein Degradation and Inhibitors 17
- Histone Deacetylase Inhibitors Research 11
- Retinoids in leukemia and cellular processes 11
- Oncology 38
- Cancer-related Molecular Pathways 10
- Peptidase Inhibition and Analysis 9
- Co-authors
- Bo Yang (75 shared papers)Qiaojun He (90 shared papers)Meidan Ying (53 shared papers)Hong Zhu (44 shared papers)Jiang Li (12 shared papers)Bin Lu (3 shared papers)Hening Lin (13 shared papers)Xuejing Shao (23 shared papers)
- Journals
- Acta Pharmacologica Sinica (10 papers)Acta Pharmaceutica Sinica B (7 papers)Frontiers in Pharmacology (6 papers)Pharmacological Research (5 papers)Nature Communications (4 papers)
- Partner nations
- ChinaUnited StatesCzechia
In The Last Decade
Ji Cao
134 papers receiving 5.3k citations
Ji Cao's Hit Papers
Peers
Comparison fields: 5 of 143
- Cancer Research 1.2k
- Geriatrics and Gerontology 215
- Molecular Biology 3.2k
- Oncology 1.2k
- Immunology 696
Countries citing papers authored by Ji Cao
This map shows the geographic impact of Ji Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ji Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ji Cao more than expected).
Fields of papers citing papers by Ji Cao
This network shows the impact of papers produced by Ji Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ji Cao. The network helps show where Ji Cao may publish in the future.
Co-authors
The 25 scholars most cited alongside Ji Cao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 142 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Role of Ferroptosis in Cancer Development and Treatment Response Hit paper breakdown → | 2018 | 348 |
| 2 | 2020 | 282 | |
| 3 | 2020 | 203 | |
| 4 | 2004 | 162 | |
| 5 | 2020 | 133 | |
| 6 | 2019 | 132 | |
| 7 | 2018 | 132 | |
| 8 | 2017 | 121 | |
| 9 | 2010 | 115 | |
| 10 | 2019 | 114 | |
| 11 | 2018 | 113 | |
| 12 | 2014 | 109 | |
| 13 | 2017 | 103 | |
| 14 | 2014 | 96 | |
| 15 | 2016 | 86 | |
| 16 | 2014 | 80 | |
| 17 | 2018 | 80 | |
| 18 | 2013 | 78 | |
| 19 | 2020 | 77 | |
| 20 | 2019 | 75 |
About Ji Cao
Ji Cao is a scholar working on Molecular Biology, Oncology, Cancer Research, Cell Biology and Pulmonary and Respiratory Medicine, having authored 142 papers that have together received 5.4k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (31 papers), Cancer, Hypoxia, and Metabolism (18 papers), Protein Degradation and Inhibitors (17 papers), Histone Deacetylase Inhibitors Research (11 papers), Retinoids in leukemia and cellular processes (11 papers), Autophagy in Disease and Therapy (10 papers), Cancer-related Molecular Pathways (10 papers) and Peptidase Inhibition and Analysis (9 papers). The work is most often cited by research in Cancer Research (1.2k citations), Geriatrics and Gerontology (215 citations), Molecular Biology (3.2k citations), Oncology (1.2k citations) and Immunology (696 citations). Ji Cao has collaborated with scholars based in China, United States and Czechia. Frequent co-authors include Bo Yang, Qiaojun He, Meidan Ying, Hong Zhu, Jiang Li, Bin Lu, Hening Lin, Xuejing Shao, Qiao He and Yuan Meng. Their work appears in journals such as Acta Pharmacologica Sinica, Acta Pharmaceutica Sinica B, Frontiers in Pharmacology, Pharmacological Research and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.